BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1344815)

  • 1. Signet cell melanocytic lesions.
    LiVolsi VA; Brooks JJ; Soslow R; Johnson BL; Elder DE
    Mod Pathol; 1992 Sep; 5(5):515-20. PubMed ID: 1344815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signet-ring cell melanoma: a potential diagnostic pitfall.
    Kocovski L; Alowami S
    Am J Dermatopathol; 2014 Dec; 36(12):985-8. PubMed ID: 25321087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoblastic nerve sheath tumors: report of a distinctive variant of neural soft tissue neoplasm with adipocytic differentiation.
    Plaza JA; Wakely PE; Suster S
    Am J Surg Pathol; 2006 Mar; 30(3):337-44. PubMed ID: 16538053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signet ring basal cell carcinoma. A case study emphasizing the differential diagnosis of neoplasms with signet ring cell formation.
    Aroni K; Lazaris AC; Nikolaou I; Saetta A; Kavantzas N; Davaris PS
    Pathol Res Pract; 2001; 197(12):853-6. PubMed ID: 11795835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z; Lind AC; Humphrey PA; Sueper RH; Swanson PE; Ritter JH; Wick MR
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevi, other than dysplastic and Spitz nevi.
    Cochran AJ; Bailly C; Paul E; Dolbeau D
    Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary signet-ring cell/histiocytoid carcinoma of the eyelid: a clinicopathologic study of 5 cases and review of the literature.
    Requena L; Prieto VG; Requena C; Sarasa JL; Manzano R; Seco M; Rütten A; Kazakov DV; Cerroni L; Kutzner H
    Am J Surg Pathol; 2011 Mar; 35(3):378-91. PubMed ID: 21317710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pitfalls in the diagnosis of malignant melanoma].
    Orosz Z
    Magy Onkol; 2003; 47(1):27-39. PubMed ID: 12704452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmoplastic nevus: clinicopathologic keynotes.
    Ferrara G; Brasiello M; Annese P; Francione S; Giorgio CM; Moscarella E; Zalaudek I; Argenziano G
    Am J Dermatopathol; 2009 Oct; 31(7):718-22. PubMed ID: 19684509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
    Sexton M; Sexton CW
    Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signet ring cell angiosarcoma: a hitherto unreported pitfall in the diagnosis of epithelioid cutaneous malignancies.
    Salviato T; Bacchi CE; Luzar B; Falconieri G
    Am J Dermatopathol; 2013 Aug; 35(6):671-5. PubMed ID: 23538897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.
    Wong RP; Khosravi S; Martinka M; Li G
    Oncol Rep; 2008 Apr; 19(4):933-7. PubMed ID: 18357378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
    McCluggage WG; Bissonnette JP; Young RH
    Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
    Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
    Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.